NextGen Healthcare Solutions
Bound Therapeutics, LLC
HOME
(current)
ABOUT
Leadership
Scientific Advisers
Business Advisers
Partnerships
SCIENCE
MicroRNA Platform Technology
Program & Pipeline
Publications
INVESTORS
Business Model
Intellectual Property
NEWS & MEDIA
Press Release
Events & Presentations
Meet the Leadership
Phong Tran, USNR
Business Advisor
Preventive medicine officer
Contributed to 11 INDs, 4 NDAs with 32 years in the industry: RNA (Regulus, Ionis, Pfizer), GPCR, Peptide (Arena, Cortex, UCI, CoCensys, ACEA)
Director of BioPharma BD (Alfa Wassermann), Senior Director of SME RNA Pharmacology (WuXi AppTec)
Advisor to BioPharma and MedTech companies, and TechSpert, a consulting firm based in Cambridge, UK.
Eric Wickstrom, Ph.D.
Co-Founder and Chief Scientific Officer
Former Professor at Thomas Jefferson University
Pioneered antisense knockdown and PET imaging of cancer gene mRNA. Over 180 publications
$20M federal and private research grants. Eight awarded patents
Yuanyuan Jin, Ph.D.
Co-Founder and Chief Operating Officer
13 years of experience in antisense drug development and tissue targeted delivery to cancer
Inventor of paradigm shifting platform to block cancer-driving RNAs
One issued patent
Jason Mazzaroth, M.S.
Chief Technology Officer
Specialist in molecular dynamics, artificial intelligence, and bioinformatics for drug design
Inventor of Bound Therapeutics' proprietary computer program for molecular design